Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesThe pragmatic use of apomorphine at the end of life
Palliative Medicine, 10/30/09
Dewhurst F et al. – Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short–acting D1/D2 dopamine agonist administered sub–cutaneously that is used in the treatment of PD. This case highlights its potential benefits for symptom control at the end of life.
Related Articles
The Effects of Apomorphine on Visual Perception in Patients With Parkinson Disease and Visual Hallucinations: A Pilot Study
Clinical Neuropharmacology, 10/02/09
Relevance Score: 88%
Inhalation Device Allows Novel Administration of Apomorphine in Men with Erectile Dysfunction - Efficacy and Safety Findings
The Journal of Sexual Medicine, 10/30/09
Relevance Score: 87%
The ANKK1 Gene Associated with Addictions Is Expressed in Astroglial Cells and Upregulated by Apomorphine
Biological Psychiatry, 10/28/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Pediatrics, 12/11/09
Emerging technologies in the delivery of erythropoietin for therapeutics
Medicinal Research Reviews, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor